Investing in the biotechnology sector doesn’t have to be fraught with excessive risk. A case in point would be CRISPR Therapeutics (NASDAQ:CRSP), as CRSP stock offers outstanding value in a market that’s often overpriced. CRISPR’s mission is “Creating transformative gene-based medicines for serious diseases.” The company’s pipeline of therapeutic candidates address serious conditions such as sickle-cell
0 Comments
I have always wondered about why the memesters decided they liked Clover Health (NASDAQ:CLOV) stock. Source: Shutterstock Maybe it was the short squeeze, which came after Hindenburg Research issued a February report calling the business broken. Maybe it was Chamath Palihapitiya, whom I have likened to Prof. Harold Hill of The Music Man. (Full disclosure:
0 Comments
Cathie Wood Source: CNBC Cathie Wood called out Michael Burry on social media after ‘The Big Short’ investor placed a bet against her flagship ARK Innovation exchange-traded fund. “To his credit, Michael Burry made a great call based on fundamentals and recognized the calamity brewing in the housing/mortgage market. I do not believe that he
0 Comments
The EBITDA margin is considered to be a good indicator of a company’s financial condition because it evaluates a company’s performance without needing to take into account financial decisions, accounting decisions or various tax environments. EBITDA Margin The EBITDA margin measures a company’s earnings before interest, tax, depreciation, and amortization as a percentage of the company’s
0 Comments
Todd Bunton, CFA, Growth & Income Stock Strategist at Zacks Investment Research, discusses in this article, http://www.zacks.com/stock/news/180276/this-weeks-growth-amp-income-stock-lyondellbasell-lyb, a stock that might be worth a closer look by investors: LyondellBasell (LYB). This plastics, chemicals and refining company recently delivered a big positive earnings surprise as profit margins expanded rapidly for its products. This prompted analysts to
0 Comments
In this article PSTH Bill Ackman’s troubled SPAC was hit with a lawsuit Tuesday alleging the blank-check company promised “staggering compensation” to directors and asking that the entity’s special status be revoked. The plaintiffs — former Securities and Exchange Commission commissioner Robert Jackson and Yale law professor John Morley — claim that Pershing Square Tontine
0 Comments
Solar energy has become a hot investment theme. Companies in the alternative energy industry are currently on a mission to help the global economy shift away from fossil fuels toward solar energy. This transition is expected to take many years as well as trillions of dollars, creating a compelling opportunity for long-term investors. Therefore, we
0 Comments